KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardelyx (ARDX) Cash & Equivalents (2016 - 2026)

Ardelyx (ARDX) has disclosed Cash & Equivalents for 14 consecutive years, with $31.2 million as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 1.3% year-over-year to $31.2 million; the TTM value through Mar 2026 reached $31.2 million, up 1.3%, while the annual FY2025 figure was $68.0 million, 4.72% up from the prior year.
  • Cash & Equivalents hit $31.2 million in Q1 2026 for Ardelyx, down from $68.0 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $96.1 million in Q4 2022 and bottomed at $21.5 million in Q4 2023.
  • Average Cash & Equivalents over 5 years is $52.3 million, with a median of $47.1 million recorded in 2022.
  • Year-over-year, Cash & Equivalents plummeted 77.67% in 2023 and then soared 202.43% in 2024.
  • Ardelyx's Cash & Equivalents stood at $96.1 million in 2022, then tumbled by 77.67% to $21.5 million in 2023, then skyrocketed by 202.43% to $64.9 million in 2024, then rose by 4.72% to $68.0 million in 2025, then plummeted by 54.1% to $31.2 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $31.2 million, $68.0 million, and $42.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.